Skip to main content
. 2020 Jul 6;20(3):2881–2887. doi: 10.3892/ol.2020.11814

Figure 3.

Figure 3.

Factors influencing the survival of patients with bladder cancer. (A-C) Kaplan-Meier survival curves; (A) High expression of APE1 was associated with shorter OS; (B) VEGFA expression was not significantly associated with OS; (C) a high ratio of CD163+ tumor-associated macrophages was associated with shorter OS. (D) ROC curves of APE1, VEGFA and CD163 were assessed with T stage and N stage for best prediction efficiency. VEGFA, vascular endothelial growth factor A; APE1, apurinic/apyrimidinic endodeoxyribonuclease 1; OS, overall survival; ROC, receiver operating characteristic; m, months.